These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32913244)

  • 1. Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015.
    Nekkab N; Crépey P; Astagneau P; Opatowski L; Temime L
    Sci Rep; 2020 Sep; 10(1):14910. PubMed ID: 32913244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    Roux J; Nekkab N; Colomb-Cotinat M; Astagneau P; Crépey P
    J Antimicrob Chemother; 2021 Jan; 76(1):226-232. PubMed ID: 32929455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of carbapenemase-producing Enterobacteriaceae in a low incidence area: A six-year experience in a university hospital.
    Emery A; Jeanvoine A; Bailly P; Gbaguidi-Haore H; Hocquet D; Bertrand X
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):936-938. PubMed ID: 31203818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
    Lepelletier D; Batard E; Berthelot P; Zahar JR; Lucet JC; Fournier S; Jarlier V; Grandbastien B
    Rev Med Interne; 2015 Jul; 36(7):474-9. PubMed ID: 25600328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark].
    Wang M; Ellermann-Eriksen S; Hansen DS; Kjerulf A; Fuglsang-Damgaard D; Holm A; Østergaard C; Røder B; Sönksen UW; Detlefsen M; Hansen F; Hasman H; Hammerum A; Skov RL
    Ugeskr Laeger; 2016 Nov; 178(45):. PubMed ID: 27855770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
    Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
    J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global epidemiology of carbapenemase-producing Enterobacteriaceae.
    van Duin D; Doi Y
    Virulence; 2017 May; 8(4):460-469. PubMed ID: 27593176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Xpert
    Hoyos-Mallecot Y; Ouzani S; Dortet L; Fortineau N; Naas T
    Int J Antimicrob Agents; 2017 Jun; 49(6):774-777. PubMed ID: 28411078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England.
    Coope CM; Verlander NQ; Schneider A; Hopkins S; Welfare W; Johnson AP; Patel B; Oliver I
    J Hosp Infect; 2018 Aug; 99(4):381-389. PubMed ID: 29530741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2017 Nov; 65(12):2144-2149. PubMed ID: 29020228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.
    Schneider A; Coope C; Michie S; Puleston R; Hopkins S; Oliver I
    BMC Health Serv Res; 2019 Oct; 19(1):689. PubMed ID: 31606053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.